Open Access · CC BY-NC 4.0
Role of Vaginal Bromocriptine in Symptomatic Management of Adenomyosis
Journal of Clinical Gynecology and Obstetrics · 2025
DOI: 10.14740/jcgo1531 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Gynecology and Obstetrics, 2025. Verfasst von Mita Mandal und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Mandal, M., Sarkar, S., Panda, S., & Kamal, V. K. (2025). Role of Vaginal Bromocriptine in Symptomatic Management of Adenomyosis. Journal of Clinical Gynecology and Obstetrics. https://doi.org/10.14740/jcgo1531
Vancouver
Mandal M, Sarkar S, Panda S, Kamal VK. Role of Vaginal Bromocriptine in Symptomatic Management of Adenomyosis. Journal of Clinical Gynecology and Obstetrics. 2025. doi:10.14740/jcgo1531
BibTeX
@article{Mandal2025,
author = {Mandal, Mita and Sarkar, Subhankar and Panda, Subrat and Kamal, Vineet Kumar},
title = {Role of Vaginal Bromocriptine in Symptomatic Management of Adenomyosis},
journal = {Journal of Clinical Gynecology and Obstetrics},
year = {2025},
doi = {10.14740/jcgo1531}
}
EUVIMED